BDTX-189, a novel tyrosine kinase inhibitor, inhibits cell activity via ERK and AKT pathways in the EGFR C797S triple mutant cells.

tuxobertinib (BDTX-189) - Black Diamond Therap

http://www.ncbi.nlm.nih.gov/pubmed/38710274

Chenxue Liu; Chenyang Liu; Chunhong Chu; Guoliang Zhang; Huixia Xu; Ke Wang; Lanxin Li; Lei An; Rui Wang; Wenrui Cui; Xiangkai Wei; Yanming Li

May 7, 2024